NEFL and amyotrophic lateral sclerosis: While none of the antigens reduced the effect on neuropathology and the characteristic body weight loss, vaccination with a peptide including the disease-associated pS409/410 site significantly reduced NfL levels, the gold standard biomarker for ALS progression.